메뉴 건너뛰기
Pediatric Blood and Cancer
Volumn 54, Issue 2, 2010, Pages 189-190
Erwinia asparaginase: Coming closer to an understanding of its use in pediatric acute lymphoblastic leukemia?
Author keywords

[No Author keywords available]
Indexed keywords

ASPARAGINASE;
EID: 74849100686     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22311     Document Type: Review
Times cited : (7)
References (6)
  • 1
    • 0032145202 scopus 로고    scopus 로고
    • Use of L-asparaginase in Childhood ALL
    • Muller HS, Boos J. Use of L-asparaginase in Childhood ALL. Crit Rev Oncol Hematol 1998;26:97-113.
    • (1998) Crit Rev Oncol Hematol , vol.26 , pp. 97-113
    • Muller, H.S.1    Boos, J.2
  • 2
    • 0035283163 scopus 로고    scopus 로고
    • Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01
    • Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01. Blood 2001;97:1211-1218.
    • (2001) Blood , vol.97 , pp. 1211-1218
    • Silverman, L.B.1    Gelber, R.D.2    Dalton, V.K.3
  • 3
    • 0027414441 scopus 로고
    • Asparaginase revisited
    • Capizzi RL. Asparaginase revisited. Leuk Lymphoma 1993;10:147-150.
    • (1993) Leuk Lymphoma , vol.10 , pp. 147-150
    • Capizzi, R.L.1
  • 4
    • 33846882147 scopus 로고    scopus 로고
    • Results of the Dana-Farber Cancer Institute ALL Consoritum Protocl 95-01 for children with acute lymphoblastic leukemia
    • Moghrabi A, Levy DE, Asselin B, et al. Results of the Dana-Farber Cancer Institute ALL Consoritum Protocl 95-01 for children with acute lymphoblastic leukemia. Blood 2007;109:896-904.
    • (2007) Blood , vol.109 , pp. 896-904
    • Moghrabi, A.1    Levy, D.E.2    Asselin, B.3
  • 5
    • 0344699390 scopus 로고    scopus 로고
    • Pharmacokinetic dose adjustment of Erwinia asparaginasea in protocol II of the paediatric ALL/NHL-BFM treatment protocols
    • Vieira Pinheiro JP, Ahlke E, Nowak-Gottl U, et al. Pharmacokinetic dose adjustment of Erwinia asparaginasea in protocol II of the paediatric ALL/NHL-BFM treatment protocols. Br J Haematol 1999;104:313-320.
    • (1999) Br J Haematol , vol.104 , pp. 313-320
    • Vieira Pinheiro, J.P.1    Ahlke, E.2    Nowak-Gottl, U.3
  • 6
    • 0027197614 scopus 로고
    • Comparative pharmacokinetic studies of three asparaginase preparations
    • Asselin BL, Whitin JC, Coppola DJ, et al. Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 1993;11:1780-1786.
    • (1993) J Clin Oncol , vol.11 , pp. 1780-1786
    • Asselin, B.L.1    Whitin, J.C.2    Coppola, D.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.